Additionally, trastuzumab can also inhibit cell proliferation and induce apoptosis by blocking PI3K/Akt signaling pathway and inhibit VEGF to decrease cell invasion by inactivating the same pathway and thus reduce tumor growth [170]. Here, AKT1 is linked to neoplasm.